Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events)
Clinical trial NCT01327846 · COMPLETED
Trial details
- NCT number
- NCT01327846
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-04-11
- Primary completion
- 2017-03-28
- Enrollment
- 10066
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.